Pub Date : 2022-12-08DOI: 10.18786/2072-0505-2022-50-046
A. V. Kotelnikova, A. Kukshina, Anastasia S. Tikhonova, Anna V. Khaustova
Rationale: Pain is the most prevalent symptom of any disease, with back pain comprising 12 to 33%. Chronic back pain ranges fourth among the causes of disability. About 60% of patients with chronic pain have symptoms of depression. However, there is paucity of empirical data on psychological aspects of the pain syndrome chronization in patients with back pain. Aim: To study the temporary transformation of the internal image of disorder in patients with chronic back pain. Materials and methods: In this observational cohort analytical study, we evaluated the contribution of pain duration into the formation of the internal image of disorder in 84 patients with chronic pain lasting for up to 55 years and caused by dorsopathy. The patients (53 women and 31 men aged 23 to 86 years, with pain intensity of up to moderate degree) were those admitted to an in-patient department for the secondary medical rehabilitation. The internal image of disorder was operationalized with the following psychometric scales: McGill Pain Questionnaire, the Restoration of the Locus of Control Scale, the Tampa Scale of Kinesiophobia, and the Psychological Factors of Attitudes to the Disease and its Treatment Scale. Results: The sensory level of the internal image of disorder was characterized by mixed (neuropathic and dysfunctional) pain in 29 (34.5%) of the cases and nociceptive pain in 55 (65.5%) of the cases. In the patients with nociceptive pain, the duration of pain was negatively correlated with their perception of self-efficacy towards the disease (the intellectual level of the internal image of disorder). With time, their self-confidence and the ability to get rid of pain was decreasing (R = -0.32, p = 0.02). The decrease looked like waning fluctuations with a maximum decline rate in the second year of the disease. Conclusion: During the first year from the disease manifestation, patients with nociceptive pain are convinced that they have all necessary resources to cope with the disease; mandatory psychological support should be provided to them in the second year, with a dramatic drop of their self-efficacy. As for patients with mixed types of pain, the inclusion of sessions with a medical psychologist into their individual rehabilitation plan is advisable regardless of the duration of the pain syndrome.
理由:疼痛是所有疾病中最普遍的症状,其中背部疼痛占12%至33%。慢性背痛在致残原因中排名第四。大约60%的慢性疼痛患者有抑郁症状。然而,缺乏关于背痛患者疼痛综合征的心理方面的经验数据。目的:探讨慢性腰痛患者内部紊乱影像的暂时性转变。材料和方法:在这项观察性队列分析研究中,我们评估了84例由背部病变引起的慢性疼痛持续长达55年的患者,疼痛持续时间对疾病内部形象形成的影响。患者(女性53例,男性31例,年龄23 ~ 86岁,疼痛强度可达中等程度)为住院二级医学康复患者。障碍的内在意象采用以下心理测量量表进行操作:麦吉尔疼痛问卷、控制源恢复量表、坦帕运动恐惧症量表和疾病态度心理因素及其治疗量表。结果:障碍内象感觉水平表现为混合性(神经性和功能失调性)疼痛29例(34.5%),痛觉性疼痛55例(65.5%)。在痛觉性疼痛患者中,疼痛持续时间与他们对疾病的自我效能感(疾病内部形象的智力水平)呈负相关。随着时间的推移,他们的自信心和摆脱痛苦的能力逐渐下降(R = -0.32, p = 0.02)。这种下降看起来像是在疾病的第二年以最大的下降率逐渐减弱的波动。结论:在疾病出现后的第一年,痛觉性疼痛患者确信自己有一切必要的资源来应对疾病;在第二年应该对他们进行强制性的心理支持,他们的自我效能感会急剧下降。对于混合型疼痛的患者,无论疼痛综合征持续多久,建议将与医学心理学家的会面纳入其个人康复计划。
{"title":"Time-dependent transformations of the internal image of disorder in patients with chronic back pain","authors":"A. V. Kotelnikova, A. Kukshina, Anastasia S. Tikhonova, Anna V. Khaustova","doi":"10.18786/2072-0505-2022-50-046","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-046","url":null,"abstract":"Rationale: Pain is the most prevalent symptom of any disease, with back pain comprising 12 to 33%. Chronic back pain ranges fourth among the causes of disability. About 60% of patients with chronic pain have symptoms of depression. However, there is paucity of empirical data on psychological aspects of the pain syndrome chronization in patients with back pain. \u0000Aim: To study the temporary transformation of the internal image of disorder in patients with chronic back pain. \u0000Materials and methods: In this observational cohort analytical study, we evaluated the contribution of pain duration into the formation of the internal image of disorder in 84 patients with chronic pain lasting for up to 55 years and caused by dorsopathy. The patients (53 women and 31 men aged 23 to 86 years, with pain intensity of up to moderate degree) were those admitted to an in-patient department for the secondary medical rehabilitation. The internal image of disorder was operationalized with the following psychometric scales: McGill Pain Questionnaire, the Restoration of the Locus of Control Scale, the Tampa Scale of Kinesiophobia, and the Psychological Factors of Attitudes to the Disease and its Treatment Scale. \u0000Results: The sensory level of the internal image of disorder was characterized by mixed (neuropathic and dysfunctional) pain in 29 (34.5%) of the cases and nociceptive pain in 55 (65.5%) of the cases. In the patients with nociceptive pain, the duration of pain was negatively correlated with their perception of self-efficacy towards the disease (the intellectual level of the internal image of disorder). With time, their self-confidence and the ability to get rid of pain was decreasing (R = -0.32, p = 0.02). The decrease looked like waning fluctuations with a maximum decline rate in the second year of the disease. \u0000Conclusion: During the first year from the disease manifestation, patients with nociceptive pain are convinced that they have all necessary resources to cope with the disease; mandatory psychological support should be provided to them in the second year, with a dramatic drop of their self-efficacy. As for patients with mixed types of pain, the inclusion of sessions with a medical psychologist into their individual rehabilitation plan is advisable regardless of the duration of the pain syndrome.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"2012 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86413509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-21DOI: 10.18786/2072-0505-2022-50-041
E. Belousova
The progressive myoclonic epilepsies syndrome (PME) is a heterogeneous group of genetic disorders characterized by myoclonus, progressive motor and cognitive abnormalities, sensory and cerebellar symptoms, abnormal slowing of the basic bioelectrical activity at electroencephalography, and normal cognitive functions and normal development of the patient before manifestation of the disease. Generalized spike-wave complexes at electroencephalography have been also described as an obligatory symptom. The Unverricht-Lundborg disease is a distinct entity within the group with specific age at manifestation (7 to 13 years), as well as slow cognitive and motor decline with stabilization in the adult age. In 90% of the cases, the diagnosis is confirmed by identification of the expanded nucleotide duplicates in the CSTB gene. An adequately tailored anticonvulsant treatment can stabilize and improve the patient's condition. The anticonvulsant therapy should not include sodium channel blockers. Valproate sodium is considered to be the main agent; it is usually combined with levetiracetam/zonisamide/topiramate/benzodiazepins. In the recent years, perampanel has been also used as a part of the combination treatment.
{"title":"The Unverricht-Lundborg disease as a part of the progressive myoclonic epilepsies syndrome","authors":"E. Belousova","doi":"10.18786/2072-0505-2022-50-041","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-041","url":null,"abstract":"The progressive myoclonic epilepsies syndrome (PME) is a heterogeneous group of genetic disorders characterized by myoclonus, progressive motor and cognitive abnormalities, sensory and cerebellar symptoms, abnormal slowing of the basic bioelectrical activity at electroencephalography, and normal cognitive functions and normal development of the patient before manifestation of the disease. Generalized spike-wave complexes at electroencephalography have been also described as an obligatory symptom. The Unverricht-Lundborg disease is a distinct entity within the group with specific age at manifestation (7 to 13 years), as well as slow cognitive and motor decline with stabilization in the adult age. In 90% of the cases, the diagnosis is confirmed by identification of the expanded nucleotide duplicates in the CSTB gene. An adequately tailored anticonvulsant treatment can stabilize and improve the patient's condition. The anticonvulsant therapy should not include sodium channel blockers. Valproate sodium is considered to be the main agent; it is usually combined with levetiracetam/zonisamide/topiramate/benzodiazepins. In the recent years, perampanel has been also used as a part of the combination treatment.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75499270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-21DOI: 10.18786/2072-0505-2022-50-043
E. Moskvina, L. Volkova, O. Koryakina
The prevalence of cognitive impairment in patients with multiple sclerosis is 40 to 65%. Improvement of cognitive-oriented therapy and search for its new techniques is considered to be promising for slowing the progression or for recovery of cognitive functions. It is related to low efficacy of medical treatment, preserved neuroplasticity in most patients with multiple sclerosis, positive results of studies on selected cognitive rehabilitation techniques in other nervous system disorders. The spectrum of techniques for cognitive training varies from technically feasible methods using a sheet of paper and a pen to the most advanced ones, such as the use of immersive virtual reality. The effectiveness of cognitive rehabilitation in patients with multiple sclerosis with virtual reality technologies has not been studied in large-scale randomized placebo-controlled studies.
{"title":"Сognitive rehabilitation methods in multiple sclerosis patients","authors":"E. Moskvina, L. Volkova, O. Koryakina","doi":"10.18786/2072-0505-2022-50-043","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-043","url":null,"abstract":"The prevalence of cognitive impairment in patients with multiple sclerosis is 40 to 65%. Improvement of cognitive-oriented therapy and search for its new techniques is considered to be promising for slowing the progression or for recovery of cognitive functions. It is related to low efficacy of medical treatment, preserved neuroplasticity in most patients with multiple sclerosis, positive results of studies on selected cognitive rehabilitation techniques in other nervous system disorders. The spectrum of techniques for cognitive training varies from technically feasible methods using a sheet of paper and a pen to the most advanced ones, such as the use of immersive virtual reality. The effectiveness of cognitive rehabilitation in patients with multiple sclerosis with virtual reality technologies has not been studied in large-scale randomized placebo-controlled studies.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73085770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-17DOI: 10.18786/2072-0505-2022-50-042
I. Ilovayskaya
The condition of a patient with acromegaly is significantly influenced not only by growth hormone (GH) and insulin-like growth factor type 1 (IGF-1) levels, but also by specific characteristics of somatotropinoma, severity of the main symptoms of acromegaly, and concomitant disorders. After successful achievement of biochemical control (GH and IGF-1 goals) the expected life longevity in patients with acromegaly could be comparable with that in the general population. It is important to avoid therapeutic inertia, to achieve biochemical control within shortest time period and to carefully tailor the treatment of concomitant disorders. The cumulative experience of patient management has shown that therapeutic decisions should be based not only on measurement of GH and IGF-1 levels, but also on a unified multifactorial assessment of the patient's status. For this purpose, the SAGIT tool has been elaborated, which ensures a multifaceted standardized assessment of patients with acromegaly, taking into account clinical symptoms, hormonal parameters, tumor size and comorbidities. This paper is the first description of the SAGIT tool in Russian. The use of this tool allows for standardization of the patients assessment and for comparison of the status in patients both within one center and in different centers. The key unified information obtained with SAGIT could be the basis for making prompt decisions on the need in treatment optimization for a patient with acromegaly, including his/hers referral to an expert center for the choice of further treatment strategy. The SAGIT tool has been recommended for implementation into clinical practice by international professional associations. It is advisable to perform studies with participation of the Russian patients with acromegaly to assess the possibility of SAGIT implementation into clinical practice in Russia.
{"title":"Optimization of the follow-up and treatment of patients with acromegaly with the SAGIT® tool","authors":"I. Ilovayskaya","doi":"10.18786/2072-0505-2022-50-042","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-042","url":null,"abstract":"The condition of a patient with acromegaly is significantly influenced not only by growth hormone (GH) and insulin-like growth factor type 1 (IGF-1) levels, but also by specific characteristics of somatotropinoma, severity of the main symptoms of acromegaly, and concomitant disorders. After successful achievement of biochemical control (GH and IGF-1 goals) the expected life longevity in patients with acromegaly could be comparable with that in the general population. It is important to avoid therapeutic inertia, to achieve biochemical control within shortest time period and to carefully tailor the treatment of concomitant disorders. \u0000The cumulative experience of patient management has shown that therapeutic decisions should be based not only on measurement of GH and IGF-1 levels, but also on a unified multifactorial assessment of the patient's status. For this purpose, the SAGIT tool has been elaborated, which ensures a multifaceted standardized assessment of patients with acromegaly, taking into account clinical symptoms, hormonal parameters, tumor size and comorbidities. This paper is the first description of the SAGIT tool in Russian. The use of this tool allows for standardization of the patients assessment and for comparison of the status in patients both within one center and in different centers. The key unified information obtained with SAGIT could be the basis for making prompt decisions on the need in treatment optimization for a patient with acromegaly, including his/hers referral to an expert center for the choice of further treatment strategy. \u0000The SAGIT tool has been recommended for implementation into clinical practice by international professional associations. It is advisable to perform studies with participation of the Russian patients with acromegaly to assess the possibility of SAGIT implementation into clinical practice in Russia.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78811192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-17DOI: 10.18786/2072-0505-2022-50-040
Anastasia I. Mezenchuk, O. Kubryak
A quantitative assessment of stability (body balance, equilibrium) and sensory support of the upright position, with identification of the "contributions" from various sensory systems, is the basis for the force plate tests similar to the Romberg's test. The purpose of this paper is to describe the Romberg's test evolution from its introduction to objective quantitative force plate tests (stabilometry) in the context of studies into the sensory support of the upright position in humans. The use of force plates for quantitative characterization of the body balance in the upright position with changing sensory conditions has added a higher sensitivity and accuracy to this assessment, providing for a more precise differentiation of various conditions. The tests originating from the Romberg's one but performed on a force plate can be considered as a quantitative investigation into the functioning of the sensory systems participating in the support of the upright position, as well as a tool for the assessment of their isolated contributions and central integration. The value of such tests for clinical medicine is related to a higher level of verification of the body balance abnormalities in various disorders, with an improvement of diagnosis and potential for differential diagnosis. With these assessments being non-invasive, it is feasible to use them for evaluation of changes of the upright equilibrium over time under treatment and rehabilitation procedures in neurology, traumatology and orthopedics, otolaryngology, sports medicine and other areas.
{"title":"The Romberg's sign: from walking in the dark to tests on the force plate","authors":"Anastasia I. Mezenchuk, O. Kubryak","doi":"10.18786/2072-0505-2022-50-040","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-040","url":null,"abstract":"A quantitative assessment of stability (body balance, equilibrium) and sensory support of the upright position, with identification of the \"contributions\" from various sensory systems, is the basis for the force plate tests similar to the Romberg's test. The purpose of this paper is to describe the Romberg's test evolution from its introduction to objective quantitative force plate tests (stabilometry) in the context of studies into the sensory support of the upright position in humans. The use of force plates for quantitative characterization of the body balance in the upright position with changing sensory conditions has added a higher sensitivity and accuracy to this assessment, providing for a more precise differentiation of various conditions. The tests originating from the Romberg's one but performed on a force plate can be considered as a quantitative investigation into the functioning of the sensory systems participating in the support of the upright position, as well as a tool for the assessment of their isolated contributions and central integration. The value of such tests for clinical medicine is related to a higher level of verification of the body balance abnormalities in various disorders, with an improvement of diagnosis and potential for differential diagnosis. With these assessments being non-invasive, it is feasible to use them for evaluation of changes of the upright equilibrium over time under treatment and rehabilitation procedures in neurology, traumatology and orthopedics, otolaryngology, sports medicine and other areas.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"23 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83500648","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-10DOI: 10.18786/2072-0505-2022-50-030
K. M. Koreshkova, Z. Khismatullina
Rationale: Evaluation of the role of the deep Koebner's phenomenon and traumatization seems to be a promising direction in the search of the solution for the delayed diagnosis of psoriatic arthritis (PsA) in patients with psoriasis. We have put forward the question if joint and ligament abnormalities induced by a trauma or persistent physical activity could be an analogue of the skin isomorphic reaction in psoriasis. Aim: To identify joint and ligament abnormalities in patients with psoriasis caused by mechanical stress and their association with the deep Koebner's phenomenon and PsA. Materials and methods: This was an open-label, non-randomized, comparative study in parallel groups in 80 in-patients with psoriasis (recruited in the Dermatovenereological clinic № 1, Ufa); the control group included 80 in-patients with PsA. All patients were assessed by a dermatovenereologist, including past history, severity of psoriasis, degree of PsA activity, special questionnaires and the presence of an isomorphic reaction in the skin and periarticular tissues. The joints with maximal physical activity were assessed by X-ray. PsA was diagnosed by a rheumatologist. Results: The patients from both groups were matched in terms of age, gender, and duration of psoriasis. Pain, joint stiffness and limitation of mobility were present not only in the PsA group, but also in the patients with psoriasis (35%, 27.5% and 26.2% of the patients, respectively). Despite most of the patients in the psoriasis group had no active complaints (65.0% vs. 0% in the control group, p 0.001), clinical signs of inflammation of the tendons and entheses and relevant history were found in 47.5% (68.7% in the control group, p = 0.007). Hand tendinitis was most prevalent symptom in both groups: 40.0% (32/80) in the psoriasis group and 63.7% (51/80) in the PsA group (p = 0.003). Achilles tendon lesions were found in 17.5% (14/80) and 52.5% (42/80) (p 0.001) and periarticular edema in 27.5% (22/80) and 63.7% (51/80), respectively (p 0.001). The combination of these signs with psoriatic plaques in this area was observed in 32.5% (26/80) and 92.5% (74/80) of the patients, respectively (p 0.001). The comparison of the clinical and X-ray data showed that 38 patients with psoriasis and newly diagnosed PsA had had an increased physical load on the affected joints, as well as signs of a deep isomorphic reaction (tendinitis, periarticular edema, or enthesitis near the involved joints). In both groups, the most common form of PsA was distal one (63.2% [24/38] of the patients with newly diagnosed PsA and 58.7% [47/80] of the patients with previously diagnosed PsA, p = 0.648). Conclusion: Involvement of the periarticular tissues, as well as early, including preclinical, X-ray abnormalities in the joints of patients with psoriasis can be associated with increased physical activity and the deep Koebner's phenomenon. Therefore, even if patients with psoriasis do not have any clinical manifestations of P
{"title":"The role of the traumatic factor and isomorphic reaction in the early diagnosis of psoriatic arthritis","authors":"K. M. Koreshkova, Z. Khismatullina","doi":"10.18786/2072-0505-2022-50-030","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-030","url":null,"abstract":"Rationale: Evaluation of the role of the deep Koebner's phenomenon and traumatization seems to be a promising direction in the search of the solution for the delayed diagnosis of psoriatic arthritis (PsA) in patients with psoriasis. We have put forward the question if joint and ligament abnormalities induced by a trauma or persistent physical activity could be an analogue of the skin isomorphic reaction in psoriasis. \u0000Aim: To identify joint and ligament abnormalities in patients with psoriasis caused by mechanical stress and their association with the deep Koebner's phenomenon and PsA. \u0000Materials and methods: This was an open-label, non-randomized, comparative study in parallel groups in 80 in-patients with psoriasis (recruited in the Dermatovenereological clinic № 1, Ufa); the control group included 80 in-patients with PsA. All patients were assessed by a dermatovenereologist, including past history, severity of psoriasis, degree of PsA activity, special questionnaires and the presence of an isomorphic reaction in the skin and periarticular tissues. The joints with maximal physical activity were assessed by X-ray. PsA was diagnosed by a rheumatologist. \u0000Results: The patients from both groups were matched in terms of age, gender, and duration of psoriasis. Pain, joint stiffness and limitation of mobility were present not only in the PsA group, but also in the patients with psoriasis (35%, 27.5% and 26.2% of the patients, respectively). Despite most of the patients in the psoriasis group had no active complaints (65.0% vs. 0% in the control group, p 0.001), clinical signs of inflammation of the tendons and entheses and relevant history were found in 47.5% (68.7% in the control group, p = 0.007). Hand tendinitis was most prevalent symptom in both groups: 40.0% (32/80) in the psoriasis group and 63.7% (51/80) in the PsA group (p = 0.003). Achilles tendon lesions were found in 17.5% (14/80) and 52.5% (42/80) (p 0.001) and periarticular edema in 27.5% (22/80) and 63.7% (51/80), respectively (p 0.001). The combination of these signs with psoriatic plaques in this area was observed in 32.5% (26/80) and 92.5% (74/80) of the patients, respectively (p 0.001). The comparison of the clinical and X-ray data showed that 38 patients with psoriasis and newly diagnosed PsA had had an increased physical load on the affected joints, as well as signs of a deep isomorphic reaction (tendinitis, periarticular edema, or enthesitis near the involved joints). In both groups, the most common form of PsA was distal one (63.2% [24/38] of the patients with newly diagnosed PsA and 58.7% [47/80] of the patients with previously diagnosed PsA, p = 0.648). \u0000Conclusion: Involvement of the periarticular tissues, as well as early, including preclinical, X-ray abnormalities in the joints of patients with psoriasis can be associated with increased physical activity and the deep Koebner's phenomenon. Therefore, even if patients with psoriasis do not have any clinical manifestations of P","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74820306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-11-10DOI: 10.18786/2072-0505-2022-50-039
Sergey S. Zamudriakov, E. A. Ivanitskiy, A. A. Vyrva, V. A. Sakovich, D. B. Drobot
The choice of an optimal, most safe and physiological place in the heart for the electrode implantation is an issue to be solved by a specialist in surgery of heart arrhythmias. According to the literature, the techniques to stimulate both cardiac apex and other alternative areas are imperfect. At present, stimulation of the heart conduction system, namely, the His bundle is considered a promising area in arrhythmology. This type of stimulation is a physiological one, while it involves the His-Purkinje system. We present a successful clinical case of the electrode implantation with a two-chamber pacemaker to the heart conduction system in a 67-year-old patient with permanent atrial fibrillation. The surgical intervention made it possible to reduce the QRS length from 180 to 110 ms. This clinical case shows that the heart conduction system pacing allows for implementation of the principles of physiological stimulation in patients with impaired atrioventricular conduction. The technique with a two-chamber pacemaker is feasible in clinical practice.
{"title":"The successful selective His bundle pacing to the patient with permanent atrial fibrillation","authors":"Sergey S. Zamudriakov, E. A. Ivanitskiy, A. A. Vyrva, V. A. Sakovich, D. B. Drobot","doi":"10.18786/2072-0505-2022-50-039","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-039","url":null,"abstract":"The choice of an optimal, most safe and physiological place in the heart for the electrode implantation is an issue to be solved by a specialist in surgery of heart arrhythmias. According to the literature, the techniques to stimulate both cardiac apex and other alternative areas are imperfect. At present, stimulation of the heart conduction system, namely, the His bundle is considered a promising area in arrhythmology. This type of stimulation is a physiological one, while it involves the His-Purkinje system. We present a successful clinical case of the electrode implantation with a two-chamber pacemaker to the heart conduction system in a 67-year-old patient with permanent atrial fibrillation. The surgical intervention made it possible to reduce the QRS length from 180 to 110 ms. This clinical case shows that the heart conduction system pacing allows for implementation of the principles of physiological stimulation in patients with impaired atrioventricular conduction. The technique with a two-chamber pacemaker is feasible in clinical practice.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81106244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-27DOI: 10.18786/2072-0505-2022-50-038
V. Bazarnyi, O. Kovtun, O. Koryakina, M. Kopenkin, L. Fechina
Background: Chemotherapy-induced peripheral polyneuropathy is a major neurotoxicity of treatment for acute lymphoblastic leukemia (ALL) in children. Pathophysiological mechanisms of the injury of peripheral neural system are not fully investigated; however, some studies have shown the involvement of vascular endothelial growth factors. Aim: To evaluate plasma levels of angiogenic growth factors in children with ALL and to identify their association with the development of vincristine-induced peripheral polyneuropathy. Materials and methods: This single center prospective study included 41 patients with ALL aged 3 to 17 years. All patients were given the ALL-MB 2015 chemotherapy regimen. Depending on the vincristine-induced peripheral polyneuropathy, the patients were divided into two groups: the main group (n = 22) comprised of the patients with neurological signs and symptoms of peripheral neuropathy and the control group (n = 19), those without clinical signs of the peripheral nervous system involvement. The levels of angiogenic growth factors (VEGF-A, VEGF-D, PlGF-1, and PDGF-BB) were measured in plasma by multiparameter immunofluorescent analysis. Results: During 3 months of the follow up the chemotherapy-induced signs of peripheral polyneuropathy developed in 53.6% (n = 22) of the children. In 72.7% (n = 16) of the patients the chemotherapy-induced peripheral polyneuropathy was characterized by a combination of neurologic abnormalities with prevailing motor symptoms. The comparative analysis of plasma angiogenic growth factors in children with ALL depending on the presence or absence of the vincristine-induced peripheral polyneuropathy showed that there was a significant decrease of the VEGF-A in those with chemotherapy-induced peripheral polyneuropathy, compared to those without (Me [Q1; Q3]: 178.20 [138.40; 228.45] and 558.50 [160.10; 650.0], respectively, p 0.017). This parameter had diagnostic sensitivity of 77.7% and specificity of 76.9%. Conclusion: We have shown a high clinical value of plasma vascular endothelial growth factor (VEGF-A) level, which makes it possible to consider it as a significant biological marker of neurotoxicity in vincristine-induced peripheral polyneuropathy.
{"title":"Regulators of angiogenesis in chemotherapy-induced peripheral neuropathy","authors":"V. Bazarnyi, O. Kovtun, O. Koryakina, M. Kopenkin, L. Fechina","doi":"10.18786/2072-0505-2022-50-038","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-038","url":null,"abstract":"Background: Chemotherapy-induced peripheral polyneuropathy is a major neurotoxicity of treatment for acute lymphoblastic leukemia (ALL) in children. Pathophysiological mechanisms of the injury of peripheral neural system are not fully investigated; however, some studies have shown the involvement of vascular endothelial growth factors. \u0000Aim: To evaluate plasma levels of angiogenic growth factors in children with ALL and to identify their association with the development of vincristine-induced peripheral polyneuropathy. \u0000Materials and methods: This single center prospective study included 41 patients with ALL aged 3 to 17 years. All patients were given the ALL-MB 2015 chemotherapy regimen. Depending on the vincristine-induced peripheral polyneuropathy, the patients were divided into two groups: the main group (n = 22) comprised of the patients with neurological signs and symptoms of peripheral neuropathy and the control group (n = 19), those without clinical signs of the peripheral nervous system involvement. The levels of angiogenic growth factors (VEGF-A, VEGF-D, PlGF-1, and PDGF-BB) were measured in plasma by multiparameter immunofluorescent analysis. \u0000Results: During 3 months of the follow up the chemotherapy-induced signs of peripheral polyneuropathy developed in 53.6% (n = 22) of the children. In 72.7% (n = 16) of the patients the chemotherapy-induced peripheral polyneuropathy was characterized by a combination of neurologic abnormalities with prevailing motor symptoms. The comparative analysis of plasma angiogenic growth factors in children with ALL depending on the presence or absence of the vincristine-induced peripheral polyneuropathy showed that there was a significant decrease of the VEGF-A in those with chemotherapy-induced peripheral polyneuropathy, compared to those without (Me [Q1; Q3]: 178.20 [138.40; 228.45] and 558.50 [160.10; 650.0], respectively, p 0.017). This parameter had diagnostic sensitivity of 77.7% and specificity of 76.9%. \u0000Conclusion: We have shown a high clinical value of plasma vascular endothelial growth factor (VEGF-A) level, which makes it possible to consider it as a significant biological marker of neurotoxicity in vincristine-induced peripheral polyneuropathy.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90866164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-26DOI: 10.18786/2072-0505-2022-50-037
G. Nurullina, G. I. Akhmadullina, I. S. Maslova, Alexandra R. Nikolaeva
Background: Acromegaly is a severe neuroendocrine disorder caused by chronic overproduction of growth hormone and insulin-like growth factor 1 and associated with a variety of clinical manifestations, debilitating complications and progressive disability, if no biochemical control has been achieved. The Russian registry of hypothalamic-pituitary tumors allows for evaluation of the epidemiological, demographic and clinical characteristics of patients with acromegaly, as well as of the effectiveness of various treatment methods. Aim: To identify epidemiological and clinical characteristics and treatment efficacy for acromegaly in the patients in the Udmurt Republic. Materials and methods: We performed a cross-sectional study based on the registry of hypothalamic-pituitary tumors of the Udmurt Republic as per June 2022. It contains data from 77 patients with acromegaly. The study included 59 (76.62%) patients with the information sufficient for evaluation of the disease stage and its complications. Results: According to the registry of hypothalamic-pituitary tumors, the prevalence of acromegaly in the Udmurt Republic was 6.71 cases per 100,000 of the population. Patients with acromegaly in Udmurt Republic had a high prevalence of arthralgia, abnormally large feet and hands, weakness/fatigue, snoring / sleep apnea, increased sweating, dizziness, peripheral edema, obesity, menstrual cycle abnormalities, diabetes mellitus, nodular goiter, pathological fractures and hypopituitarism. Neurosurgery has been performed in 74.57% (n = 44) of the patients, with a remission of acromegaly achieved in 18 (40.9%). Medical treatment was given to 25/59 (42.37%) of the patients, with 22 of them being treated with 1st generation long-acting somatostatin analogues. Radiation therapy has been administered to 13 patients (22.03%). Biochemical control was achieved in 40/59 (67.8%) of patients with acromegaly, related to neurosurgery in most patients, as well as to the use of a growth hormone receptor antagonist and/or combined medical treatment. Conclusion: The prevalence of acromegaly in the Udmurt Republic is consistent with international data. Clinical characteristics of acromegaly generally correspond to the classic disease course, although a number of symptoms are more commonly found in the Udmurt Republic patients than in the Russian Federation registry; this might be related to the quality of the registry management. The effectiveness of treatment for acromegaly in Udmurt Republic is comparable to the international data.
{"title":"Clinical characteristics and efficacy of acromegaly treatment in the Udmurt Republic","authors":"G. Nurullina, G. I. Akhmadullina, I. S. Maslova, Alexandra R. Nikolaeva","doi":"10.18786/2072-0505-2022-50-037","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-037","url":null,"abstract":"Background: Acromegaly is a severe neuroendocrine disorder caused by chronic overproduction of growth hormone and insulin-like growth factor 1 and associated with a variety of clinical manifestations, debilitating complications and progressive disability, if no biochemical control has been achieved. The Russian registry of hypothalamic-pituitary tumors allows for evaluation of the epidemiological, demographic and clinical characteristics of patients with acromegaly, as well as of the effectiveness of various treatment methods. \u0000Aim: To identify epidemiological and clinical characteristics and treatment efficacy for acromegaly in the patients in the Udmurt Republic. \u0000Materials and methods: We performed a cross-sectional study based on the registry of hypothalamic-pituitary tumors of the Udmurt Republic as per June 2022. It contains data from 77 patients with acromegaly. The study included 59 (76.62%) patients with the information sufficient for evaluation of the disease stage and its complications. \u0000Results: According to the registry of hypothalamic-pituitary tumors, the prevalence of acromegaly in the Udmurt Republic was 6.71 cases per 100,000 of the population. Patients with acromegaly in Udmurt Republic had a high prevalence of arthralgia, abnormally large feet and hands, weakness/fatigue, snoring / sleep apnea, increased sweating, dizziness, peripheral edema, obesity, menstrual cycle abnormalities, diabetes mellitus, nodular goiter, pathological fractures and hypopituitarism. Neurosurgery has been performed in 74.57% (n = 44) of the patients, with a remission of acromegaly achieved in 18 (40.9%). Medical treatment was given to 25/59 (42.37%) of the patients, with 22 of them being treated with 1st generation long-acting somatostatin analogues. Radiation therapy has been administered to 13 patients (22.03%). Biochemical control was achieved in 40/59 (67.8%) of patients with acromegaly, related to neurosurgery in most patients, as well as to the use of a growth hormone receptor antagonist and/or combined medical treatment. \u0000Conclusion: The prevalence of acromegaly in the Udmurt Republic is consistent with international data. Clinical characteristics of acromegaly generally correspond to the classic disease course, although a number of symptoms are more commonly found in the Udmurt Republic patients than in the Russian Federation registry; this might be related to the quality of the registry management. The effectiveness of treatment for acromegaly in Udmurt Republic is comparable to the international data.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"02 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85964540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2022-10-21DOI: 10.18786/2072-0505-2022-50-031
O. Bondarenko, Marianna V. Yaroslavceva, A. Y. Tokmakova, G. Galstyan, N. Tarbaeva
The paper presents a clinical case of the patient with long-term poor control of type 1 diabetes mellitus, chronic kidney disease (CKD) and diabetic neurоosteoarthropathy. The characteristics of interest in the clinical case are CKD complications associated with mineral and bone metabolism disorders. Clinical consequences of vascular calcification due to secondary hyperparathyroidism, autonomic and peripheral neuropathy have resulted in cardiovascular complications. We discuss the diagnostic challenges of vascular calcification, as well as the interpretation of diagnostic methods in lower limb arterial disease, and provide evidence for the advantages of alternative treatment of secondary hyperparathyroidism with a selective activator of vitamin D receptors. The important role of CKD in the development of metabolic, structural and hemodynamic disorders in patients with type 1 diabetes mellitus is emphasized.
{"title":"Comprehensive assessment of cardiovascular complications in a patient with type 1 diabetes mellitus, chronic kidney disease and diabetic neuroosteoarthropathy","authors":"O. Bondarenko, Marianna V. Yaroslavceva, A. Y. Tokmakova, G. Galstyan, N. Tarbaeva","doi":"10.18786/2072-0505-2022-50-031","DOIUrl":"https://doi.org/10.18786/2072-0505-2022-50-031","url":null,"abstract":"The paper presents a clinical case of the patient with long-term poor control of type 1 diabetes mellitus, chronic kidney disease (CKD) and diabetic neurоosteoarthropathy. The characteristics of interest in the clinical case are CKD complications associated with mineral and bone metabolism disorders. Clinical consequences of vascular calcification due to secondary hyperparathyroidism, autonomic and peripheral neuropathy have resulted in cardiovascular complications. We discuss the diagnostic challenges of vascular calcification, as well as the interpretation of diagnostic methods in lower limb arterial disease, and provide evidence for the advantages of alternative treatment of secondary hyperparathyroidism with a selective activator of vitamin D receptors. The important role of CKD in the development of metabolic, structural and hemodynamic disorders in patients with type 1 diabetes mellitus is emphasized.","PeriodicalId":7638,"journal":{"name":"Almanac of Clinical Medicine","volume":"97 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81636503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}